Viewing Study NCT05972967


Ignite Creation Date: 2025-12-25 @ 12:27 AM
Ignite Modification Date: 2026-01-11 @ 3:37 AM
Study NCT ID: NCT05972967
Status: COMPLETED
Last Update Posted: 2025-10-01
First Post: 2023-07-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Patients With a Sub-optimal Response to Ravulizumab
Sponsor: Omeros Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Paroxysmal Nocturnal Hemoglobinuria View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PNH View